Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (161)

Latest Posts

About This Stock More About This Stock
Growth Is Struggling – Sunday, April 17
Article By: Dividend Power
Sunday, April 17, 2022 7:45 AM EDT
Growth stocks are struggling in 2022. This fact was apparent last week when I wrote about Buffett is Buying. However, this fact is not surprising.
In this article: CVX, DOW, KO, MRK, AMGN, DIA, IWD, IWF
Read
Best Biotech Stocks To Buy In 2022
Article By: Elliottwave Forecast
Tuesday, March 15, 2022 6:42 AM EDT
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and pharmaceuticals, genomics, and food and chemical manufacturing.
In this article: BMY, JNJ, PFE, NVAX, REGN, AMGN, VRTX, AXSM, GMAB, RLAY
Read
"Prudent" Biotech Bets
Article By: MoneyShow.com
Sunday, February 20, 2022 2:00 PM EDT
Here, we review two recommended biotechnology stocks following the release of their latest earnings reports. Let's take a look.
In this article: AMGN, GILD Also: GSK, RCUS
Read
Is Amgen (AMGN) A Good Stock To Buy?
Article By: Dividend Power
Tuesday, January 25, 2022 7:26 AM EDT
The pharmaceutical sector has a lot of big companies that pay a growing dividend, and AMGN is one of them.
In this article: AMGN
Read
3 Pharma Stocks Yielding Over 3%
Article By: Dividend Power
Tuesday, January 18, 2022 7:48 AM EDT
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.
In this article: BMY, MRK, AMGN Also: XBI, XPH
Read

Latest Tweets for $AMGN

No tweets yet!

PARTNER HEADLINES

$AMGN

Market Briefing For Wednesday, Aug.25
Adam Reynolds 8/25/2021 9:13:55 AM

How much will #Amgen pay to acquire #Sorrento? 🤔
$SRNE $AMGN

July 2017 Stock Considerations
Dick Kaplan 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 2 of 2 comments